Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
NCT04565925Phase 2Active, not recruiting
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jul 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ASP-001 in urinary incontinence (UI) (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Bladder Leakage at 4 weeks. Started Jul 2021; status: active, not recruiting.
02
Drugs
ASP-001
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT04565925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04565925.